ctDNA monitoring using tumor-informed copy number analysis
Ze Zhou, Ros Cutts, Sarah Hrebien, Christina Zhang et autres
gb, il (code pays fourni par la source)
2 citations
EMBO Molecular Medicine
Ros Cutts
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
65Publications signalées
1828Citations signalées
4Affiliations récentes
Les institutions déclarées
Les domaines associés
Cancer Genomics and DiagnosticsFibroblast Growth Factor ResearchBRCA gene mutations in cancerEosinophilic Disorders and SyndromesGenetics, Bioinformatics, and Biomedical Research
Les publications récentes
Comparison of NGS-based (HPV-Detect) and ddPCR plasma HPV-DNA assays for treatment response estimation in head and neck cancer in the INOVATE study
Shreerang Bhide, Monisha Dewan, Jen Lee, Aida Marku et autres
us, gb (code pays fourni par la source)
0 citations
Radiotherapy and Oncology
Abstract P1-01-19: Predicting response to capivasertib in AKT1 mutant advanced breast cancer
Sarah Mearns, Alexander T. Pearson, Ros Cutts, Heena Shah et autres
0 citations
Clinical Cancer Research
Inhibition of GPX4 enhances CDK4/6 inhibitor and endocrine therapy activity in breast cancer
María Teresa Herrera-Abreu, Jingwen Guan, Usman Khalid, Jian Ning et autres
gb, ca, us (code pays fourni par la source)
39 citations
Nature Communications
108O Heterogeneity of endocrine resistance in estrogen-receptor-positive breast cancer
Anton Patrikeev, Shibing Deng, C English, Cristiane Martin et autres
gb, us (code pays fourni par la source)
0 citations
ESMO Open
Discriminating subtypes in advanced breast cancer with ctDNA methylation profiling.
Nida Pasha, Ros Cutts, Aya Amenssag, Sarah Hrebien et autres
gb (code pays fourni par la source)
1 citation
Journal of Clinical Oncology
Ultra-sensitive ctDNA mutation tracking to identify molecular residual disease and predict relapse in patients with early breast cancer.
Isaac García-Murillas, Ros Cutts, Charles W. Abbott, Sean Michael Boyle et autres
gb, us (code pays fourni par la source)
18 citations
Journal of Clinical Oncology
Circulating HPV DNA as a Biomarker for Pre-Invasive and Early Invasive Cervical Cancer: A Feasibility Study
Stacey Bryan, Jen Lee, Richard Gunu, Allison Jones et autres
gb (code pays fourni par la source)
12 citations
Cancers
Supplementary Figure 4 from High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical Trial
Alexander T. Pearson, Elizabeth Smyth, Irina S. Babina, María Teresa Herrera-Abreu et autres
0 citations
Supplementary Figure 6 from High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical Trial
Alexander T. Pearson, Elizabeth Smyth, Irina S. Babina, María Teresa Herrera-Abreu et autres
0 citations
Supplementary Figure 5 from High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical Trial
Alexander T. Pearson, Elizabeth Smyth, Irina S. Babina, María Teresa Herrera-Abreu et autres
0 citations
Supplementary Figure 1 from High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical Trial
Alexander T. Pearson, Elizabeth Smyth, Irina S. Babina, María Teresa Herrera-Abreu et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.